Rethink Tomorrow

Board of Directors

Our nine-member Board of Directors and six-member Executive Leadership Team comprise broad and global management experience, comprehensive biotech expertise and in-depth knowledge of Novozymes' business. The members' competencies combine to ensure the best possible management of the company.

Henrik Gürtler*

Born 1953. Chairman of the Board since 2000. Elected for one year at a time.

Jørgen Buhl Rasmussen

Born 1955. Vice Chairman of the Board since 2016. Adjunct Professor at Copenhagen Business School. Member of the Board since 2011. Member of the Audit Committee. Elected for one year at a time.

Heinz-Jürgen Bertram

Born 1958. President & CEO, Symrise AG (Germany). Member of the Board since 2015. Elected for one year at a time.

Lars Green*

Born 1967. Senior Vice President, Finance & Operations, Novo Nordisk Inc. (US). Member of the Board since 2014. Elected for one year at a time.

Agnete Raaschou-Nielsen

Born 1957. Member of the Audit Committee. Member of the Board since 2011. Elected for one year at a time

Mathias Uhlén

Born 1954. Professor at the Royal Institute of Technology (KTH) in Sweden and the Technical University of Denmark (DTU). Member of the Board since 2007. Elected for one year at a time.